Infarmed alerted this Wednesday, April 8th, to the lack of the medication Metoprolol Aurobindo, 100 mg, film-coated tablet (60 units) until May 18th. It is indicated for “hypertension, angina pectoris, tachycardic arrhythmia (particularly supraventricular tachycardia), prevention of cardiac death and new heart attack (after an acute phase of myocardial infarction) and migraine prophylaxis”.
According to a information circular from the medicine authoritythe drug “is in rupture of stockfor reasons related to manufacturing”, until May 18th.
“The company responsible for marketing the medicine – Generis Farmacêutica, SA – is making efforts to bring forward the date of receipt of the next batch and still has stock of this medicine with an expiration date that ends on 07/31/2026″, says the note.
In this sense, Infarmed, “considering the clinical relevance” of the medicine and “the need to ensure continuity of treatments”, also indicates that “entities that purchase it must take into account that its use by the patient is possible until the last day of the expiration date”, the last day of July this year.
Leave a Reply